iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.85+0.10 (+13.37%)
Close on Nov 18, 2026Market cap $54.54MP/E –Yield –
iBio net income
Net income is the profit left for shareholders after every expense, interest and tax.
iBio's net income for the twelve months ending Sep 30, 2026 was -$34.88M. For fiscal 2026 it was -$33.04M. The highest annual figure on record is -$3.67M in fiscal 2014.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$33.04M | – |
| FY2025 | Jun 30, 2025 | -$18.38M | – |
| FY2024 | Jun 30, 2024 | -$24.91M | – |
| FY2023 | Jun 30, 2023 | -$65.01M | – |
| FY2022 | Jun 30, 2022 | -$50.30M | – |
| FY2021 | Jun 30, 2021 | -$23.21M | – |
| FY2020 | Jun 30, 2020 | -$16.44M | – |
| FY2019 | Jun 30, 2019 | -$17.59M | – |
| FY2018 | Jun 30, 2018 | -$16.11M | – |
| FY2017 | Jun 30, 2017 | -$14.53M | – |
| FY2016 | Jun 30, 2016 | -$9.76M | – |
| FY2015 | Jun 30, 2015 | -$6.63M | – |
| FY2014 | Jun 30, 2014 | -$3.67M | – |
| FY2013 | Jun 30, 2013 | -$6.20M | – |
| FY2012 | Jun 30, 2012 | -$5.68M | – |
| FY2011 | Jun 30, 2011 | -$12.14M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$7.55M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$10.60M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$7.73M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$8.99M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$5.72M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$5.16M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$4.86M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$4.36M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$3.99M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$7.78M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$3.17M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$8.21M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$5.75M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$6.03M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$7.29M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$33.55M | -29025.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$18.13M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$17.05M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$12.39M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $116.00K | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$7.66M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$8.13M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$7.53M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$3.54M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$4.68M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$3.76M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$4.46M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$4.50M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$4.22M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$4.47M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$4.40M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$4.42M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$3.96M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$3.90M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$3.83M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$4.33M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$3.91M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$3.23M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$3.06M | – |
See a number that looks wrong?